D. Wentworth

发表

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

M. Johnson, A. Kelleher, D. Murray, 2015, PloS one.

How to construct an optimal interim report: What the data monitoring committee does and doesn’t need to know

J. Neaton, B. Grund, D. Wentworth, 2018, Clinical trials.

Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

J. Neaton, J. Stamler, D. Wentworth, 1993, Diabetes Care.

Sequence Analysis of In Vivo Defective Interfering-Like RNA of Influenza A H1N1 Pandemic Virus

Timothy B. Stockwell, T. Stockwell, E. Holmes, 2013, Journal of Virology.

Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

A. Dyer, P. Greenland, Kiang Liu, 1999, JAMA.

Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

J. Cutler, L. Kuller, J. Stamler, 1987, JAMA.

Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

D. Jacobs, J. Neaton, D. Wentworth, 1989, The New England journal of medicine.

Cigarette smoking and mortality

L. Kuller, J. Ockene, E. Meilahn, 1991 .

Impact of systolic and diastolic blood pressure on cardiovascular mortality

L. Kuller, J. Neaton, J. Stamler, 1995 .

Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.

J. Cutler, L. Kuller, J. Neaton, 1993, Annals of epidemiology.

Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial

K. Dickstein, M. Komajda, F. Zannad, 2012, European journal of heart failure.

Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial

J. Neaton, J. Stamler, D. Wentworth, 1998 .

The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.

L. Kuller, J. Ockene, E. Meilahn, 1989, The American review of respiratory disease.

Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

S B Hulley, W. Kannel, J. Neaton, 1986, American heart journal.

Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

D. Jacobs, L. Kuller, H. Blackburn, 1992, Archives of internal medicine.

Prevalence and prognostic significance of hypercholesterolemia in men with hypertension. Prospective data on the primary screenees of the Multiple Risk Factor Intervention Trial.

J. Neaton, J. Stamler, D. Wentworth, 1986, The American journal of medicine.

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

R. Dewar, J. Metcalf, R. Davey, 2016, The Journal of infectious diseases.

Influence of serum cholesterol, blood pressure, and cigarette smoking on death from coronary heart disease in 316,099 white men aged 35-57 years: Overall findings and differences by age

J. Neaton, D. Wentworth, 1992 .

Cigarette smoking and mortality. MRFIT Research Group.

L. Kuller, J. Ockene, E. Meilahn, 1991, Preventive medicine.

Low serum cholesterol and risk of death from AIDS.

J. Neaton, D. Wentworth, 1997, AIDS.

Outcomes of Influenza A(H1N1)pdm09 Virus Infection: Results from Two International Cohort Studies

R. Davey, H. Lane, J. Lundgren, 2014, PloS one.

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Kamil H A Kim, A. Ginde, R. Paredes, 2022, Annals of Internal Medicine.

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Samuel M. Brown, Christina C. Chang, W. Self, 2020, The New England Journal of Medicine.

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

Kamil H A Kim, A. Ginde, R. Paredes, 2022, Annals of Internal Medicine.

Data Monitoring Experience in the AIDS Toxoplasmic Encephalitis Study

J. Neaton, D. Wentworth, M. Jacobson, 2006 .

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

A. Mocroft, O. Kirk, M. Johnson, 2015, PLoS medicine.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection

R. Davey, H. Lane, S. Kent, 2018, The Journal of infectious diseases.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years.

L. Kuller, N. Borhani, J. Neaton, 1984, American heart journal.

Serum cholesterol concentration and primary malignant brain tumors: a prospective study.

Y. Ben-Shlomo, J. Neaton, D. Wentworth, 1992, American journal of epidemiology.

Data analysis issues for protocols with overlapping enrollment.

K. Larntz, J. Neaton, D. Wentworth, 1996, Statistics in medicine.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Long term effects of intermittent IL 2 in HIV infection : extended follow

D. Wentworth, N. Markowitz, A. Babiker, 2019 .

Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO)

J. Lundgren, A. Gelijns, J. Neaton, 2022, Med.

Risk factors for death from different types of stroke

J. Cutler, L. Kuller, J. Neaton, 1993 .

Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men

James D. Neaton, J. Neaton, D. Wentworth, 1992 .

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.

J P Matts, J. Neaton, D. Wentworth, 1994, The Journal of infectious diseases.

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

J. Neaton, J. Stamler, D. Wentworth, 1986, JAMA.

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy

T. Merigan, W. Verbiest, J. Neaton, 2002, AIDS.

Interleukin-2 therapy in patients with HIV infection.

H. Lane, D. Cooper, A. Phillips, 2009, The New England journal of medicine.

Blood Pressure (Systolic and Diastolic) and Risk of Fatal Coronary Heart Disease

J. Neaton, J. Stamler, D. Wentworth, 1989, Hypertension.

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels

Samuel M. Brown, Christina C. Chang, W. Self, 2021, Annals of Internal Medicine.

Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of < 500/mm3. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J. Neaton, D. Wentworth, D. Abrams, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV

A. Mocroft, D. Wentworth, B. Angus, 2010, AIDS.

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

S. Lees, D. Watson-Jones, P. Piot, 2022, The New England journal of medicine.

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

D. Watson-Jones, Y. Yazdanpanah, J. Neaton, 2021, Trials.

Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

J. Neaton, D. Wentworth, F. Rhame, 1994, Statistics in medicine.

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy

T. Merigan, M. Winters, J. Neaton, 2000 .

Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: I. White men.

J. Neaton, J. Stamler, D. Wentworth, 1996, American journal of public health.

Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers

C. Sabin, J. Lundgren, J. Neaton, 2013, AIDS.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

Rebecca Hoh, Peter Bacchetti, Matthew C Strain, 2013, The Journal of infectious diseases.

Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy

J. Lundgren, J. Neaton, B. Grund, 2016, PloS one.

Frequency of Antiretroviral Drug Resistance Mutations in HIV-1 Strains from Patients Failing Triple Drug Regimens

T. Merigan, M. Winters, J. Neaton, 2000, Antiviral therapy.

Long-Term Effects of Intermittent IL-2 in HIV Infection: Extended Follow-Up of the INSIGHT STALWART Study

Abdel Babiker, Norman Markowitz, D. Wentworth, 2012, PloS one.

Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial

D. Jacobs, L. Kuller, H. Blackburn, 1992 .

SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN

L. Kuller, W. Browner, S. Hulley, 1986, The Lancet.

Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT

G. Smith, J. Neaton, J. Stamler, 1998, The Lancet.

An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status.

J. Neaton, D. Wentworth, W. Rasmussen, 1983, American journal of public health.

Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

K. Chaloner, M. Max, D. Wentworth, 1998, JAMA.

Life Styles and Life Style Related Major Risk Factors: Their Combined Impact in Producing Epidemic Cardiovascular Disease, and the Potential for Prevention

J. Neaton, A. Dyer, D. Wentworth, 1992 .

Quality of life in advanced heart failure: role of mitral regurgitation.

T. Rector, D. Wentworth, S. Kubo, 2006, American heart journal.

Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial.

L. Kuller, W. M. Smith, R. Mcdonald, 1988, Circulation.

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group.

J. Neaton, D. Wentworth, J D Neaton, 1992, Archives of internal medicine.

Development and validation of a patient questionnaire to determine New York Heart Association classification.

D. Burkhoff, D. Wentworth, R. Starling, 2004, Journal of cardiac failure.

The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies

R. Dewar, J. Metcalf, R. Davey, 2013, PloS one.

An examination of the efficiency of some quality assurance methods commonly employed in clinical trials.

A. G. Duchene, J. Neaton, D. Wentworth, 1990, Statistics in medicine.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

A clinically useful risk-score for chronic kidney disease in HIV infection

A. Mocroft, O. Kirk, M. Johnson, 2014, Journal of the International AIDS Society.

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.

Jacques Fellay, Amalio Telenti, Huldrych F Günthard, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: II. Black men.

J. Neaton, J. Stamler, D. Wentworth, 1996, American journal of public health.

Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy

R. Paredes, A. Winston, J. Neaton, 2014, PloS one.

Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic

Henrik Nielsen, L. Mathiesen, C. Leen, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Why Patients Continue to Participate in Clinical Research

A. Wertheimer, C. Duncombe, D. Wentworth, 2008 .

Interleukin-2 Therapy in Patients with HIV Infection

J. Routy, D. Wentworth, G. Tambussi, 2009 .

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

R. Dewar, J. Metcalf, R. Davey, 2016, The Journal of infectious diseases.